Article
Impact of Glutathione S-Transferase Polymorphisms on Busulfan Pharmacokinetics and Outcomes of Hematopoietic Stem Cell Transplantation.
Therapeutic drug monitoring - 1 Aug 2022
Al-Riyami Intisar, Al-Khabori Murtadha, Al Balushi Khalid, Al-Zadjali Shoaib, Al-Rawahi Mohammed, Dennison David, Al-Hunaini Mohammed, Al-Rawas Abdulhakeem, Al-Moundhri Mansour
Abstract excerpt
BACKGROUND: Busulfan (Bu) is an alkylating drug used in many preparative regimens before hematopoietic stem cell transplantation (HSCT). It is conjugated in the liver mainly by glutathione S-transferase isoenzyme A1-1 ( GSTA1 ). Genetic polymorphisms in these isoenzymes may affect the pharmacokinetics of Bu and the clinical outcomes of HSCT. This study aimed to assess the impact of glutathione S-transferase ( GST...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
